In a major milestone in the development of therapies and diagnostics for multiple sclerosis (MS) researchers at The Ottawa Hospital and the University of Ottawa have discovered a protein called Neuro-C-Cbl has been found in a patients blood.

The discovery is important because it will lead to a definitive diagnosis and possible treatments that will help patients.

MS can be a lot easier to diagnose because the symptoms tend to be more subtle and not as noticeable said Dr. Lee Richardson who worked on the project along with Tom Lukens the Canada Research Chair in MS. MS can be most easily managed if a patient is diagnosed with central nervous system disorders. Once you get that blood test then we can infer that it could be one of the pieces in the puzzle that will guide diagnosis to the right treatment.